Medical News

RSS

OLYSIO (simeprevir) receives EC marketing authorisation for treatment of genotype 1 and 4 CHC

Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.

16 May 2014

PFF Patient Communication Center: The destination for latest disease education information

The newly launched Pulmonary Fibrosis Foundation Patient Communication Center (PCC) has become the destination for the most up-to-date information for the pulmonary fibrosis community. The PCC now has information about the Expanded Access Program (EAP) for pirfenidone.

16 May 2014

Ariz. Gov. Brewer asks state Supreme Court to throw out challenge to her Medicaid expansion plan

The governor's lawyers filed an appeal Wednesday arguing that the lawmakers who filed the initial lawsuit an appeals court ruling did not have standing to post the challenge.

16 May 2014

Chronic bystander viral impairs development of memory T cells

Studies of vaccine programs in the developing world have revealed that individuals with chronic infections such as malaria and hepatitis tend to be less likely to develop the fullest possible immunity benefits from vaccines for unrelated illnesses.

16 May 2014

Kamada announces top-line results from Phase II/III trial for treatment of inherited emphysema

Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, announces preliminary top-line results from the Phase II/III pivotal clinical trial in Europe and Canada of the Company's proprietary inhaled Alpha-1 Antitrypsin (AAT) therapy for the treatment of Alpha-1 Antitrypsin Deficiency (AATD or inherited emphysema).

16 May 2014

Specific Technologies unveils SpecID blood culture system at General Meeting of the American Society for Microbiology

Specific Technologies, developer of the SpecID™ system to rapidly detect and identify bacterial species and strain via a metabolomic fingerprint, today announced that for the first time it will showcase its transformative SpecID blood culture system at the 114th General Meeting of the American Society for Microbiology, May 17-20, 2014 in Boston, Massachusetts at the Boston Convention and Exhibition Center.

16 May 2014

TCM announces winners of 26th Annual Industry Awards

The Tech Council of Maryland (TCM), Maryland's largest technology trade association for life science and technology, today announced the winners of its 26th Annual Industry Awards.

16 May 2014

Abbott signs definitive agreement to acquire CFR Pharmaceuticals

Abbott today announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding Abbott's presence in fast-growing markets.

16 May 2014

First Edition: May 16, 2014

Today's headlines include reports about the Indiana governor's alternative plan to expand Medicaid. Kaiser Health News staff writer Sarah Varney, working in collaboration with PBS Newshour, reports: "Men and women involved in the criminal justice system are more likely to be sicker than the general population, with higher rates of diabetes, hypertension, depression, mood disorders and alcohol and drug addiction.

16 May 2014

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Data from a retrospective pooled analysis of eight phase III trials (two 18-week and six 24-week) of linagliptin 5 mg once-daily, showed reductions from baseline A1c at 18 (eight trials) and 24 (six trials) weeks compared to placebo in African-American adults with type 2 diabetes (T2D),

16 May 2014

New research shows decline in clinical trials handled by CROs

The number of clinical trials started by leading contract research organisations (CROs) dropped by 50% between 2011 and 2013, according to new research from global pharmaceutical analyst firm Datamonitor Healthcare.

16 May 2014

Cook Medical to exhibit augmented reality experiences at AUA meeting

Cook Medical will exhibit augmented reality experiences, which is a technology used to simulate use of products, and host a skills challenge at their booth, #1617, at the annual American Urological Association meeting.

From COOK MEDICAL INC. 16 May 2014

Bristol-Myers Squibb announces study results of nivolumab drug in patients with renal cell carcinoma

Bristol-Myers Squibb Company today announced results from a Phase 2 and a Phase 1b study of its investigational PD-1 immune checkpoint inhibitor nivolumab in patients with advanced or metastatic renal cell carcinoma (RCC), commonly known as kidney cancer.

16 May 2014

Provectus’ shares to begin trading on NYSE MKT on May 16, 2014

Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that its shares will begin trading on the NYSE MKT today, Friday, May 16, 2014.

16 May 2014

MD Anderson Cancer Center, Concord Medical sign consulting agreement for cancer hospital projects

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company"), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced it has engaged The University of Texas MD Anderson Cancer Center ("MD Anderson") as a consultant for its cancer hospital projects under planning in Shanghai and Beijing.

16 May 2014

Kymab raises US$40 million in Series B financing

Kymab, a monoclonal antibody biopharmaceutical company, announced today it has successfully raised US$40 million in a Series B financing.

16 May 2014

Standard & Poor's upgrades HTA's investment grade credit rating to BBB

Healthcare Trust of America, Inc. (NYSE: HTA) announced today that Standard & Poor's ("S&P") has upgraded HTA's investment grade credit rating to BBB, with a stable outlook.

16 May 2014

Bristol-Myers Squibb reports updated survival data from Phase 1b study of advanced melanoma

Bristol-Myers Squibb Company today announced updated survival data from the advanced melanoma cohort of Phase 1b study.

16 May 2014

TOLMAR Pharmaceuticals holds exclusive distribution rights to ELIGARD in the U.S. and Puerto Rico

TOLMAR Pharmaceuticals, Inc., focused on specialty pharmaceutical products, today announced that, effective May 8, 2014, the company holds exclusive distribution rights to ELIGARD® (leuprolide acetate for injectable suspension) in the U.S. and Puerto Rico.

16 May 2014

20th International AIDS Conference calls for end to discrimination against HIV patients

A declaration affirming that non-discrimination is fundamental to an evidence-based response to HIV and effective public health programmes was announced today by the organizers of the 20th International AIDS Conference (AIDS 2014), to be held in Melbourne, Australia, from 20-25 July 2014.

16 May 2014

Medical News

OLYSIO (simeprevir) receives EC marketing authorisation for treatment of genotype 1 and 4 CHC

PFF Patient Communication Center: The destination for latest disease education information

Ariz. Gov. Brewer asks state Supreme Court to throw out challenge to her Medicaid expansion plan

Chronic bystander viral impairs development of memory T cells

Kamada announces top-line results from Phase II/III trial for treatment of inherited emphysema

Specific Technologies unveils SpecID blood culture system at General Meeting of the American Society for Microbiology

TCM announces winners of 26th Annual Industry Awards

Abbott signs definitive agreement to acquire CFR Pharmaceuticals

First Edition: May 16, 2014

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

New research shows decline in clinical trials handled by CROs

Cook Medical to exhibit augmented reality experiences at AUA meeting

Bristol-Myers Squibb announces study results of nivolumab drug in patients with renal cell carcinoma

Provectus’ shares to begin trading on NYSE MKT on May 16, 2014

MD Anderson Cancer Center, Concord Medical sign consulting agreement for cancer hospital projects

Kymab raises US$40 million in Series B financing

Standard & Poor's upgrades HTA's investment grade credit rating to BBB

Bristol-Myers Squibb reports updated survival data from Phase 1b study of advanced melanoma

TOLMAR Pharmaceuticals holds exclusive distribution rights to ELIGARD in the U.S. and Puerto Rico

20th International AIDS Conference calls for end to discrimination against HIV patients

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News